Colonoscopy for colorectal cancer screening using hypnosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of hypnosis as an alternative to general anesthesia during colonoscopy for colorectal cancer screening. Colorectal cancer is a prevalent condition, and colonoscopy is a critical screening tool that is often performed under general anesthesia due to patient discomfort. The study aims to determine if hypnosis can reduce anxiety and pain, making the procedure more acceptable to patients while also minimizing the risks and costs associated with general anesthesia. By assessing patient tolerance and outcomes, the study seeks to provide a viable option for those undergoing screening.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients 18 years of age or older
* Undergoing a screening colonoscopy (mass screening Fecal Immunochemical Test positive or as an individual (family history of colon cancer or adenoma, personal history of adenoma, cancer, chronic inflammatory bowel disease) or in the context of a transit disorder, hemorrhage or anemia
* Affiliated with a French social security system
* Having signed a written consent

Exclusion Criteria:

* Patient requiring emergency colonoscopy
* History of colonic resection
* Carriers of behavioral disorders and/or psychiatric illness
* Limited cognitive abilities making it impossible to read or fill out a discrete choice questionnaire (language problems, comprehension problems)
* Contraindication to hypnosis, preventing quality interaction (comprehension and/or language problems, hearing impairment)
* Contraindication to general anesthesia
* Under a legal protection regime
* Pregnant or breastfeeding woman

Where it's running

• Chu Angers
  Angers, France Recruiting

Study contacts

• Principal investigator: Driffa MOUSSATA, PhD — University Hospital Center of Tours
• Study coordinator: Driffa MOUSSATA, PhD
• Email: D.MOUSSATA@chu-tours.fr
• Phone: +33 2 47 47 83 50

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Perioperative biomarker monitoring to spot complications after colorectal and gastric cancer surgery

  This randomized trial tests whether checking inflammatory and metabolic biomarkers during the perioperative period helps detect postoperative problems early in adults having colorectal or gastric cancer surgery.

  Recruiting Bucharest Emergency Hospital · Bucharest, Bucharest · NCT07881133

• Clonal Hematopoiesis Effects with Chemo and Radiation in Solid Cancers

  This study tests whether clonal hematopoiesis affects outcomes for adults with solid cancers who are receiving chemotherapy or radiation.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07675967

• BHB810 in advanced gastric and GEJ cancer (early-phase)

  This study tests whether BHB810 can be safely given every two weeks to adults with advanced gastric or GEJ adenocarcinoma and looks at its effect, how the drug behaves in the body, and patient responses.

  Recruiting at 2 sites Phase 1/2 BigHat Biosciences, Inc. · Duarte, California and 2 other locations · NCT07529808

• Biopsy and Resection Growth Patterns in Colorectal Peritoneal Cancer

  This study tests whether peritoneal growth patterns seen on small biopsies during staging laparoscopy match the patterns found in later surgical specimens for adults with colorectal peritoneal metastases.

  Recruiting Jules Bordet Institute · Brussels, Brussels Capital and 1 other locations · NCT07474025

• RC148 plus chemotherapy as first-line treatment for unresectable or metastatic colorectal cancer

  This study tests RC148 with standard chemotherapy as the first treatment for people with unresectable or metastatic colorectal cancer to see if it helps more than current therapy.

  Recruiting at 19 sites Phase 2/3 RemeGen Co., Ltd. · Beijing, Beijing Municipality and 18 other locations · NCT07462143

• Moving the uterus, ovaries, and fallopian tubes out of the pelvis before whole pelvic radiation to preserve fertility.

  This trial tries moving the uterus, ovaries, and fallopian tubes out of the pelvis before whole pelvic radiation in women aged 18–40 who want to preserve their ability to have children.

  Recruiting University of South Florida · Tampa, Florida · NCT07419490

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.